{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["ACE-2", "COVID-19", "COVID-19 main protease", "Phytoconstituents", "TMPRSS2", "nCoV-2019"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "33798507", "DateCompleted": {"Year": "2021", "Month": "05", "Day": "03"}, "DateRevised": {"Year": "2023", "Month": "03", "Day": "28"}, "Article": {"ArticleDate": [{"Year": "2021", "Month": "03", "Day": "30"}], "Language": ["eng"], "ELocationID": ["10.1016/j.cbi.2021.109449", "S0009-2797(21)00085-5"], "Journal": {"ISSN": "1872-7786", "JournalIssue": {"Volume": "341", "PubDate": {"Year": "2021", "Month": "May", "Day": "25"}}, "Title": "Chemico-biological interactions", "ISOAbbreviation": "Chem Biol Interact"}, "ArticleTitle": "Role of phytoconstituents in the management of COVID-19.", "Pagination": {"StartPage": "109449", "MedlinePgn": "109449"}, "Abstract": {"AbstractText": ["COVID-19, a severe global pandemic caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) has emerged as one of the most threatening transmissible disease. As a great threat to global public health, the development of treatment options has become vital, and a rush to find a cure has mobilized researchers globally from all areas.", "This review focuses on deciphering the potential of different secondary metabolites from medicinal plants as therapeutic options either as inhibitors of therapeutic targets of SARS-CoV-2 or as blockers of viral particles entry through host cell receptors. The use of medicinal plants containing specific phytomoieties could be seen in providing a safer and long-term solution for the population with lesser side effects. Key Findings and Conclusions: Considering the high cost and time-consuming drug discovery process, therapeutic repositioning of existing drugs was explored as treatment option in COVID-19, however several molecules have been retracted as therapeutics either due to no positive outcomes or the severe side effects. These effects call for exploring the alternate treatment options which are therapeutically effective as well as safe. Keeping this in mind, phytopharmaceuticals derived from medicinal plants could be explored as important resources in the development of COVID-19 treatment, as their role in the past for treatment of viral diseases like HIV, MERS-CoV, and influenza has been well reported. Considering this fact, different phytoconstituents such as flavonoids, alkaloids, tannins and glycosides etc. Possessing antiviral properties against coronaviruses and possessing potential against SARS-CoV-2 have been reviewed in the present work."], "CopyrightInformation": "Copyright \u00a9 2021 Elsevier B.V. All rights reserved."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Amity Institute of Molecular Medicine & Stem Cell Research (AIMMSCR), Amity University Uttar Pradesh, Sector-125, Noida, 201313, India."}], "LastName": "Das", "ForeName": "Amiya", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutics, Delhi Pharmaceutical Sciences and Research University, Pushp Vihar, New Delhi, 110017, India. Electronic address: deeptipandita@yahoo.co.uk."}], "LastName": "Pandita", "ForeName": "Deepti", "Initials": "D"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutics, Delhi Pharmaceutical Sciences and Research University, Pushp Vihar, New Delhi, 110017, India."}], "LastName": "Jain", "ForeName": "Gaurav Kumar", "Initials": "GK"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Amity Institute of Molecular Medicine & Stem Cell Research (AIMMSCR), Amity University Uttar Pradesh, Sector-125, Noida, 201313, India."}], "LastName": "Agarwal", "ForeName": "Pallavi", "Initials": "P"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Guru Gobind Singh College of Pharmacy, Yamunanagar, Haryana, India."}], "LastName": "Grewal", "ForeName": "Ajmer Singh", "Initials": "AS"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "BS Anangpuria Institute of Pharmacy, Faridabad, Haryana, India."}], "LastName": "Khar", "ForeName": "Roop K", "Initials": "RK"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Amity Institute of Pharmacy, Amity University Uttar Pradesh, Sector-125, Noida, 201313, India. Electronic address: vinnylather@gmail.com."}], "LastName": "Lather", "ForeName": "Viney", "Initials": "V"}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "Ireland", "MedlineTA": "Chem Biol Interact", "NlmUniqueID": "0227276", "ISSNLinking": "0009-2797"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Alkaloids"}, {"RegistryNumber": "0", "NameOfSubstance": "Anthraquinones"}, {"RegistryNumber": "0", "NameOfSubstance": "Antiviral Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Flavonoids"}, {"RegistryNumber": "0", "NameOfSubstance": "Oils, Volatile"}, {"RegistryNumber": "0", "NameOfSubstance": "Phytochemicals"}, {"RegistryNumber": "0", "NameOfSubstance": "Saponins"}], "MeshHeadingList": [{"QualifierName": ["chemistry", "pharmacology"], "DescriptorName": "Alkaloids"}, {"QualifierName": ["chemistry", "pharmacology"], "DescriptorName": "Anthraquinones"}, {"QualifierName": ["chemistry", "pharmacology"], "DescriptorName": "Antiviral Agents"}, {"QualifierName": ["chemistry", "pharmacology"], "DescriptorName": "Flavonoids"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["chemistry", "pharmacology"], "DescriptorName": "Oils, Volatile"}, {"QualifierName": ["chemistry", "pharmacology"], "DescriptorName": "Phytochemicals"}, {"QualifierName": ["chemistry", "metabolism"], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": ["chemistry", "pharmacology"], "DescriptorName": "Saponins"}, {"QualifierName": [], "DescriptorName": "Secondary Metabolism"}, {"QualifierName": [], "DescriptorName": "COVID-19 Drug Treatment"}], "CoiStatement": "The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "World Health Organization . World Health Organization; Geneva, Switzerland: 2020. WHO coronavirus disease (COVID-19) dashboard.https://covid19.who.int/"}, {"Citation": "Ratten V. Coronavirus (covid-19) and entrepreneurship: changing life and work landscape. J. Small Bus. Enterpren. 2020;32:503\u2013516. doi: 10.1080/08276331.2020.1790167.", "ArticleIdList": ["10.1080/08276331.2020.1790167"]}, {"Citation": "Barua S. SSRN; 2020. Understanding Coronanomics: the economic implications of the coronavirus (COVID-19) pandemic.", "ArticleIdList": ["10.2139/ssrn.3566477"]}, {"Citation": "Wu C., Liu Y., Yang Y., Zhang P., Zhong W., Wang Y., Wang Q., Xu Y., Li M., Li X., Zheng M., Chen L., Li H. Analysis of therapeutic targets for SARS-CoV-2 and discovery of potential drugs by computational methods. Acta Pharm. Sin. B. 2020;10:766\u2013788. doi: 10.1016/j.apsb.2020.02.008.", "ArticleIdList": ["10.1016/j.apsb.2020.02.008", "PMC7102550", "32292689"]}, {"Citation": "Wang Y., Wang Y., Chen Y., Qin Q. Unique epidemiological and clinical features of the emerging 2019 novel coronavirus pneumonia (COVID\u201019) implicate special control measures. J. Med. Virol. 2020;92:568\u2013576. doi: 10.1002/jmv.25748.", "ArticleIdList": ["10.1002/jmv.25748", "PMC7228347", "32134116"]}, {"Citation": "Ogen Y. Assessing nitrogen dioxide (NO2) levels as a contributing factor to the coronavirus (COVID-19) fatality rate. Sci. Total Environ. 2020;726:138605. doi: 10.1016/j.scitotenv.2020.138605.", "ArticleIdList": ["10.1016/j.scitotenv.2020.138605", "PMC7151460", "32302812"]}, {"Citation": "Onder G., Rezza G., Brusaferro S. Case-fatality rate and characteristics of patients dying in relation to COVID-19 in Italy. J. Am. Med. Assoc. 2020;323(18):1775\u20131776. doi: 10.1001/jama.2020.4683.", "ArticleIdList": ["10.1001/jama.2020.4683", "32203977"]}, {"Citation": "Decaro N., Lorusso A. Novel human coronavirus (SARS-CoV-2): a lesson from animal coronaviruses. Vet. Microbiol. 2020;244:108693. doi: 10.1016/j.vetmic.2020.108693.", "ArticleIdList": ["10.1016/j.vetmic.2020.108693", "PMC7195271", "32402329"]}, {"Citation": "Helmy Y.A., Fawzy M., Elaswad A., Sobieh A., Kenney S.P., Shehata A.A. The COVID-19 pandemic: a comprehensive review of taxonomy, genetics, epidemiology, diagnosis, treatment, and control. J. Clin. Med. 2020;9(4):1225. doi: 10.3390/jcm9041225.", "ArticleIdList": ["10.3390/jcm9041225", "PMC7230578", "32344679"]}, {"Citation": "Graham R.L., Donaldson E.F., Baric R.S. A decade after SARS: strategies for controlling emerging coronaviruses. Nat. Rev. Microbiol. 2013;11(12):836\u2013848. doi: 10.1038/nrmicro3143.", "ArticleIdList": ["10.1038/nrmicro3143", "PMC5147543", "24217413"]}, {"Citation": "Mani J.S., Johnson J.B., Steel J.C., Broszczak D.A., Neilsen P.M., Walsh K.B., Naiker M. Natural product-derived phytochemicals as potential agents against coronaviruses: a review. Virus Res. 2020;284:197989. doi: 10.1016/j.virusres.2020.197989.", "ArticleIdList": ["10.1016/j.virusres.2020.197989", "PMC7190535", "32360300"]}, {"Citation": "Abd El-Aziz T.M., Stockand J.D. Recent progress and challenges in drug development against COVID-19 coronavirus (SARS-CoV-2)-an update on the status. Infect. Genet. Evol. 2020;83:104327. doi: 10.1016/j.meegid.2020.104327.", "ArticleIdList": ["10.1016/j.meegid.2020.104327", "PMC7166307", "32320825"]}, {"Citation": "Pandey A., Nikam A.N., Shreya A.B., Mutalik S.P., Gopalan D., Kulkarni S., Padya B.S., Fernandes G., Mutalik S., Prassl R. Potential therapeutic targets for combating SARS-CoV-2: drug repurposing, clinical trials and recent advancements. Life Sci. 2020;256:117883. doi: 10.1016/j.lfs.2020.117883.", "ArticleIdList": ["10.1016/j.lfs.2020.117883", "PMC7263255", "32497632"]}, {"Citation": "Petrosillo N., Viceconte G., Ergonul O., Ippolito G., Petersen E. COVID-19, SARS and MERS: are they closely related? Clin. Microbiol. Infect. 2020;26(6):729\u2013734. doi: 10.1016/j.cmi.2020.03.026.", "ArticleIdList": ["10.1016/j.cmi.2020.03.026", "PMC7176926", "32234451"]}, {"Citation": "Zhang Y.Z., Holmes E.C. A genomic perspective on the origin and emergence of SARS-CoV-2. Cell. 2020;181:223\u2013227. doi: 10.1016/j.cell.2020.03.035.", "ArticleIdList": ["10.1016/j.cell.2020.03.035", "PMC7194821", "32220310"]}, {"Citation": "Chen N., Zhou M., Dong X., Qu J., Gong F., Han Y., Qiu Y., Wang J., Liu Y., Wei Y., Xia J., Yu T., Zhang X., Zhang L. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020;395:507\u2013513. doi: 10.1016/S0140-6736(20)30211-7. 10223.", "ArticleIdList": ["10.1016/S0140-6736(20)30211-7", "PMC7135076", "32007143"]}, {"Citation": "Vellingiri B., Jayaramayya K., Iyer M., Narayanasamy A., Govindasamy V., Giridharan B., Ganesan S., Venugopal A., Venkatesan D., Ganesan H., Rajagopalan K., Rahman P., Cho S., Kumar N., Subramaniam M. COVID-19: a promising cure for the global panic. Sci. Total Environ. 2020;725:138277. doi: 10.1016/j.scitotenv.2020.138277.", "ArticleIdList": ["10.1016/j.scitotenv.2020.138277", "PMC7128376", "32278175"]}, {"Citation": "Ashour H.M., Elkhatib W.F., Rahman M.M., Elshabrawy H.A. Insights into the recent 2019 novel coronavirus (SARS-CoV-2) in light of past human coronavirus outbreaks. Pathogens. 2020;9(3):186. doi: 10.3390/pathogens9030186.", "ArticleIdList": ["10.3390/pathogens9030186", "PMC7157630", "32143502"]}, {"Citation": "Carstens E.B. Ratification vote on taxonomic proposals to the international committee on taxonomy of viruses (2009) Arch. Virol. 2010;155(1):133\u2013146. doi: 10.1007/s00705-009-0547-x.", "ArticleIdList": ["10.1007/s00705-009-0547-x", "PMC7086975", "19960211"]}, {"Citation": "Cui J., Li F., Shi Z.L. Origin and evolution of pathogenic coronaviruses. Nat. Rev. Microbiol. 2019;17(3):181\u2013192. doi: 10.1038/s41579-018-0118-9.", "ArticleIdList": ["10.1038/s41579-018-0118-9", "PMC7097006", "30531947"]}, {"Citation": "Woo P.C., Lau S.K., Huang Y., Yuen K.Y. Coronavirus diversity, phylogeny and interspecies jumping. Exp. Biol. Med. 2009;234(10):1117\u20131127. doi: 10.3181/0903-MR-94.", "ArticleIdList": ["10.3181/0903-MR-94", "19546349"]}, {"Citation": "Qi X., Cui L., Jiao Y., Pan Y., Li X., Zu R., Huo X., Wu B., Tang F., Song Y., Zhou M., Wang H., Cardona C.J., Xing Z. Antigenic and genetic characterization of a European avian-like H1N1 swine influenza virus from a boy in China in 2011. Arch. Virol. 2013;158(1):39\u201353. doi: 10.1007/s00705-012-1423-7.", "ArticleIdList": ["10.1007/s00705-012-1423-7", "22935945"]}, {"Citation": "Corman V.M., Muth D., Niemeyer D., Drosten C. Hosts and sources of endemic human coronaviruses. Adv. Virus Res. 2018;100:163\u2013188. doi: 10.1016/bs.aivir.2018.01.001.", "ArticleIdList": ["10.1016/bs.aivir.2018.01.001", "PMC7112090", "29551135"]}, {"Citation": "To K.K., Hung I.F., Chan J.F., Yuen K.Y. From SARS coronavirus to novel animal and human coronaviruses. J. Thorac. Dis. 2013;5(Suppl2):S103\u2013S108. doi: 10.3978/j.issn.2072-1439.2013.06.02.", "ArticleIdList": ["10.3978/j.issn.2072-1439.2013.06.02", "PMC3747523", "23977429"]}, {"Citation": "Ye Z.W., Yuan S., Yuen K.S., Fung S.Y., Chan C.P., Jin D.Y. Zoonotic origins of human coronaviruses. Int. J. Biol. Sci. 2020;16(10):1686\u20131697. doi: 10.7150/ijbs.45472.", "ArticleIdList": ["10.7150/ijbs.45472", "PMC7098031", "32226286"]}, {"Citation": "Cheng R.H., Kuhn R.J., Olson N.H., Rossmann M.G., Choi H.K., Smith T.J., Baker T.S. Nucleocapsid and glycoprotein organization in an enveloped virus. Cell. 1995;80(4):621\u2013630. doi: 10.1016/0092-8674(95)90516-2.", "ArticleIdList": ["10.1016/0092-8674(95)90516-2", "PMC4167723", "7867069"]}, {"Citation": "Naqvi A.A.T., Fatima K., Mohammad T., Fatima U., Singh I.K., Singh A., Atif S.M., Hariprasad G., Hasan G.M., Hassan M.I. Insights into SARS-CoV-2 genome, structure, evolution, pathogenesis and therapies: structural genomics approach. Biochim. Biophys. Acta (BBA) - Mol. Basis Dis. 2020;1866(10):165878. doi: 10.1016/j.bbadis.2020.165878.", "ArticleIdList": ["10.1016/j.bbadis.2020.165878", "PMC7293463", "32544429"]}, {"Citation": "Li F. Structure, function, and evolution of coronavirus spike proteins. Annual Review of Virology. 2016;3:237\u2013261. doi: 10.1146/annurev-virology-110615-042301.", "ArticleIdList": ["10.1146/annurev-virology-110615-042301", "PMC5457962", "27578435"]}, {"Citation": "Abduljalil J.M., Abduljalil B.M. Epidemiology, genome, and clinical features of the pandemic SARS-CoV-2: a recent view. New Microbes and New Infections. 2020;35:100672. doi: 10.1016/j.nmni.2020.100672.", "ArticleIdList": ["10.1016/j.nmni.2020.100672", "PMC7171182", "32322400"]}, {"Citation": "Tang X., Wu C., Li X., Song Y., Yao X., Wu X., Duan Y., Zhang H., Wang Y., Qian Z., Cui J., Lu J. National Science Review; 2020. On the origin and continuing evolution of SARS-CoV-2. 2020, nwaa036.", "ArticleIdList": ["10.1093/nsr/nwaa036", "PMC7107875", "34676127"]}, {"Citation": "Chhikara B.S., Rathi B., Singh J., Poonam Corona virus SARS-CoV-2 disease COVID-19: infection, prevention and clinical advances of the prospective chemical drug therapeutics. Chemical Biology Letters. 2020;7(1):63\u201372."}, {"Citation": "Gyawali R., Paudel P.N., Basyal D., Setzer W.N., Lamichhane S., Paudel M.N., Gyawali S., Khanal P. A review on ayurvedic medicinal herbs as remedial perspective for COVID-19. JKAHS. 2020;3:1\u201321. doi: 10.3126/jkahs.v3i0.29116.", "ArticleIdList": ["10.3126/jkahs.v3i0.29116"]}, {"Citation": "Gurung A.B., Ali M.A., Lee J., Farah M.A., MashayAl-Anazi K. Unravelling lead antiviral phytochemicals for the inhibition of SARS-CoV-2 Mpro enzyme through in silico approach. Life Sci. 2020;255:117831. doi: 10.1016/j.lfs.2020.117831.", "ArticleIdList": ["10.1016/j.lfs.2020.117831", "PMC7243810", "32450166"]}, {"Citation": "Kabera J.N., Semana E., Mussa A.R., He X. Plant secondary metabolites: biosynthesis, classification, function and pharmacological properties. J. Pharm. Pharmacol. 2014;2:377\u2013392."}, {"Citation": "Parida P.K., Paul D., Chakravorty D. ChemRxiv; 2020. Nature to nurture-identifying phytochemicals from Indian medicinal plants as prophylactic medicine by rational screening to be potent against multiple drug targets of SARS-CoV-2. 2020, (Pre-print)", "ArticleIdList": ["10.26434/chemrxiv.12355937.v1"]}, {"Citation": "Belouzard S., Millet J.K., Licitra B.N., Whittaker G.R. Mechanisms of coronavirus cell entry mediated by the viral spike protein. Viruses. 2012;4(6):1011\u20131033. doi: 10.3390/v4061011.", "ArticleIdList": ["10.3390/v4061011", "PMC3397359", "22816037"]}, {"Citation": "Bosch B.J., van der Zee R., de Haan C., Rottier P. The coronavirus spike protein is a class I virus fusion protein: structural and functional characterization of the fusion core complex. J. Virol. 2013;77(16):8801\u20138811. doi: 10.1128/jvi.77.16.8801-8811.2003.", "ArticleIdList": ["10.1128/jvi.77.16.8801-8811.2003", "PMC167208", "12885899"]}, {"Citation": "Hamming I., Timens W., Bulthuis M.L., Lely A.T., Navis G., van Goor H. Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis. J. Pathol. 2004;203(2):631\u2013637. doi: 10.1002/path.1570.", "ArticleIdList": ["10.1002/path.1570", "PMC7167720", "15141377"]}, {"Citation": "Heald-Sargent T., Gallagher T. Ready, set, fuse! the coronavirus spike protein and acquisition of fusion competence. Viruses. 2012;4:557\u2013580. doi: 10.3390/v4040557.", "ArticleIdList": ["10.3390/v4040557", "PMC3347323", "22590686"]}, {"Citation": "White J.M., Delos S.E., Brecher M., Schornberg K. Structures and mechanisms of viral membrane fusion proteins: multiple variations on a common theme. Crit. Rev. Biochem. Mol. Biol. 2008;43(3):189\u2013219. doi: 10.1080/10409230802058320.", "ArticleIdList": ["10.1080/10409230802058320", "PMC2649671", "18568847"]}, {"Citation": "Bertram S., Glowacka I., M\u00fcller M.A., Lavender H., Gnirss K., Nehlmeier I., Niemeyer D., He Y., Simmons G., Drosten C., Soilleux E.J., Jahn O., Steffen I., P\u00f6hlmann S. Cleavage and activation of the severe acute respiratory syndrome coronavirus spike protein by human airway trypsin-like protease. J. Virol. 2011;85(24):13363\u201313372. doi: 10.1128/JVI.05300-11.", "ArticleIdList": ["10.1128/JVI.05300-11", "PMC3233180", "21994442"]}, {"Citation": "Shulla A., Heald-Sargent T., Subramanya G., Zhao J., Perlman S., Gallagher T. A transmembrane serine protease is linked to the severe acute respiratory syndrome coronavirus receptor and activates virus entry. J. Virol. 2011;85(2):873\u2013882. doi: 10.1128/JVI.02062-10.", "ArticleIdList": ["10.1128/JVI.02062-10", "PMC3020023", "21068237"]}, {"Citation": "Li G., De Clercq E. Therapeutic options for the 2019 novel coronavirus (2019-nCoV) Nat. Rev. Drug Discov. 2020;19(3):149\u2013150. doi: 10.1038/d41573-020-00016-0.", "ArticleIdList": ["10.1038/d41573-020-00016-0", "32127666"]}, {"Citation": "Siu Y.L., Teoh K.T., Lo J., Chan C.M., Kien F., Escriou N., Tsao S.W., Nicholls J.M., Altmeyer R., Peiris J.S., Bruzzone R., Nal B. The M, E, and N structural proteins of the severe acute respiratory syndrome coronavirus are required for efficient assembly, trafficking, and release of virus-like particles. J. Virol. 2008;82(22):11318\u201311330. doi: 10.1128/JVI.01052-08.", "ArticleIdList": ["10.1128/JVI.01052-08", "PMC2573274", "18753196"]}, {"Citation": "Nieto-Torres J.L., Verdi\u00e1-B\u00e1guena C., Jimenez-Guarde\u00f1o J.M., Regla-Nava J.A., Casta\u00f1o-Rodriguez C., Fernandez-Delgado R., Torres J., Aguilella V.M., Enjuanes L. Severe acute respiratory syndrome coronavirus E protein transports calcium ions and activates the NLRP3 inflammasome. Virology. 2015;485:330\u2013339. doi: 10.1016/j.virol.2015.08.010.", "ArticleIdList": ["10.1016/j.virol.2015.08.010", "PMC4619128", "26331680"]}, {"Citation": "Lukassen S., Chua R.L., Trefzer T., Kahn N.C., Schneider M.A., Muley T., Winter H., Meister M., Veith C., Boots A.W., Hennig B.P., Kreuter M., Conrad C., Eils R. SARS\u2010CoV\u20102 receptor ACE 2 and TMPRSS 2 are primarily expressed in bronchial transient secretory cells. EMBO J. 2020;39(10) doi: 10.15252/embj.20105114.", "ArticleIdList": ["10.15252/embj.20105114", "PMC7232010", "32246845"]}, {"Citation": "Bourgonje A.R., Abdulle A.E., Timens W., Hillebrands J.L., Navis G.J., Gordijn S.J., Bolling M.C., Dijkstra G., Voors A.A., Osterhaus A.D., van der Voort P.H., Mulder D.J., van Goor H. Angiotensin\u2010converting enzyme\u20102 (ACE2), SARS\u2010CoV\u20102 and pathophysiology of coronavirus disease 2019 (COVID\u201019) J. Pathol. 2020;251(3):228\u2013248. doi: 10.1002/path.5471.", "ArticleIdList": ["10.1002/path.5471", "PMC7276767", "32418199"]}, {"Citation": "Karthik A.R.A., Muthusamy V.S., Ramanathan M. Phytomolecules having flavone and napthofuran nucleus exhibited better binding G-score against protease and SPIKE protein of novel corona virus COVID-19. Research Square. 2020. 2020, (Pre-print)", "ArticleIdList": ["10.21203/rs.3.rs-27206/v1"]}, {"Citation": "Chakraborty I., Maity P. COVID-19 outbreak: migration, effects on society, global environment and prevention. Sci. Total Environ. 2020;728:138882. doi: 10.1016/j.scitotenv.2020.138882.", "ArticleIdList": ["10.1016/j.scitotenv.2020.138882", "PMC7175860", "32335410"]}, {"Citation": "Pang J., Wang M.X., Ang I.Y.H., Tan S.H.X., Lewis R.F., Chen J.I., Gutierrez R.A., Gwee S.X.W., Chua P.E.Y., Yang Q., Ng X.Y., Yap R.K., Tan H.Y., Teo Y.Y., Tan C.C., Cook A.R., Yap J.C., Hsu L.Y. Potential rapid diagnostics, vaccine and therapeutics for 2019 novel coronavirus (2019-nCoV): a systematic review. J. Clin. Med. 2020;9(3):623. doi: 10.3390/jcm9030623.", "ArticleIdList": ["10.3390/jcm9030623", "PMC7141113", "32110875"]}, {"Citation": "Gheblawi M., Wang K., Viveiros A., Nguyen Q., Zhong J.C., Turner A.J., Raizada M.K., Grant M.B., Oudit G.Y. Angiotensin-converting enzyme 2: SARS-CoV-2 receptor and regulator of the renin-angiotensin system: celebrating the 20th anniversary of the discovery of ACE2. Circ. Res. 2020;126(10):1456\u20131474. doi: 10.1161/CIRCRESAHA.120.317015.", "ArticleIdList": ["10.1161/CIRCRESAHA.120.317015", "PMC7188049", "32264791"]}, {"Citation": "Zhou Y., Hou Y., Shen J., Huang Y., Martin W., Cheng F. Network-based drug repurposing for novel coronavirus 2019-nCoV/SARS-CoV-2. Cell Discovery. 2020;6:14. doi: 10.1038/s41421-020-0153-3.", "ArticleIdList": ["10.1038/s41421-020-0153-3", "PMC7073332", "32194980"]}, {"Citation": "Zhang H., Penninger J.M., Li Y., Zhong N., Slutsky A.S. Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target. Intensive Care Med. 2020;46(4):586\u2013590. doi: 10.1007/s00134-020-05985-9.", "ArticleIdList": ["10.1007/s00134-020-05985-9", "PMC7079879", "32125455"]}, {"Citation": "Poduri R., Joshi G., Jagadeesh G. Drugs targeting various stages of the SARS-CoV-2 life cycle: exploring promising drugs for the treatment of Covid-19. Cell. Signal. 2020;74:109721. doi: 10.1016/j.cellsig.2020.109721.", "ArticleIdList": ["10.1016/j.cellsig.2020.109721", "PMC7375293", "32711111"]}, {"Citation": "Joshi R.S., Jagdale S.S., Bansode S.B., Shankar S.S., Tellis M.B., Pandya V.K., Chugh A., Giri A.P., Kulkarni M.J. Discovery of potential multi-target-directed ligands by targeting host-specific SARS-CoV-2 structurally conserved main protease. J. Biomol. Struct. Dyn. 2020:1\u201316. doi: 10.1080/07391102.2020.1760137. 2020.", "ArticleIdList": ["10.1080/07391102.2020.1760137", "PMC7212545", "32329408"]}, {"Citation": "Abena P.M., Decloedt E.H., Bottieau E., Suleman F., Adejumo P., Sam-Agudu N.A., Muyembe TamFum J.J., Seydi M., Eholie S.P., Mills E.J., Kallay O., Zumla A., Nachega J.B. Chloroquine and hydroxychloroquine for the prevention or treatment of COVID-19 in Africa: caution for inappropriate off-label use in healthcare settings. Am. J. Trop. Med. Hyg. 2020;102:1184\u20131188. doi: 10.4269/ajtmh.20-0290.", "ArticleIdList": ["10.4269/ajtmh.20-0290", "PMC7253100", "32323646"]}, {"Citation": "Devaux C., Rolain J., Colson P., Raoult D. New insights on the antiviral effects of chloroquine against coronavirus: what to expect for COVID-19? Int. J. Antimicrob. Agents. 2020;55(5):105938. doi: 10.1016/j.ijantimicag.2020.105938.", "ArticleIdList": ["10.1016/j.ijantimicag.2020.105938", "PMC7118659", "32171740"]}, {"Citation": "Di Trani L., Savarino A., Campitelli L., Norelli S., Puzelli S., D'Ostilio D., Vignolo E., Donatelli I., Cassone A. Different pH requirements are associated with divergent inhibitory effects of chloroquine on human and avian influenza A viruses. Virol. J. 2007;4(1):39. doi: 10.1186/1743-422X-4-39.", "ArticleIdList": ["10.1186/1743-422X-4-39", "PMC1878474", "17477867"]}, {"Citation": "Chatre C., Roubille F., Vernhet H., Jorgensen C., Pers Y.M. Cardiac complications attributed to chloroquine and hydroxychloroquine: a systematic review of the literature. Drug Saf. 2018;41(10):919\u2013931. doi: 10.1007/s40264-018-0689-4.", "ArticleIdList": ["10.1007/s40264-018-0689-4", "29858838"]}, {"Citation": "Liu J., Cao R., Xu M., Wang X., Zhang H., Hu H., Li Y., Hu Z., Zhong W., Wang M. Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2 infection in vitro. Cell Discovery. 2020;6:16. doi: 10.1038/s41421-020-0156-0.", "ArticleIdList": ["10.1038/s41421-020-0156-0", "PMC7078228", "32194981"]}, {"Citation": "Zhang J., Xie B., Hashimoto K. Current status of potential therapeutic candidates for the COVID-19 crisis. Brain Behav. Immun. 2020;87:59\u201373. doi: 10.1016/j.bbi.2020.04.046.", "ArticleIdList": ["10.1016/j.bbi.2020.04.046", "PMC7175848", "32334062"]}, {"Citation": "Geleris J., Sun Y., Platt J., Zucker J., Baldwin M., Hripcsak G., Labella A., Manson D.K., Kubin C., Barr R.G., Sobieszczyk M.E., Schluger N.W. Observational study of hydroxychloroquine in hospitalized patients with Covid-19. N. Engl. J. Med. 2020;382:2411\u20132418. doi: 10.1056/NEJMoa2012410.", "ArticleIdList": ["10.1056/NEJMoa2012410", "PMC7224609", "32379955"]}, {"Citation": "Liu C., Zhou Q., Li Y., Garner L.V., Watkins S.P., Carter L.J., Smoot J., Gregg A.C., Daniels A.D., Jervey S., Albaiu D. Research and development on therapeutic agents and vaccines for COVID-19 and related human coronavirus diseases. ACS Cent. Sci. 2020;6:315\u2013331. doi: 10.1021/acscentsci.0c00272.", "ArticleIdList": ["10.1021/acscentsci.0c00272", "PMC10467574", "32226821"]}, {"Citation": "Gallagher T.M., Buchmeier M.J. Coronavirus spike proteins in viral entry and pathogenesis. Virology. 2001;279(2):371\u2013374. doi: 10.1006/viro.2000.0757.", "ArticleIdList": ["10.1006/viro.2000.0757", "PMC7133764", "11162792"]}, {"Citation": "Hoffmann M., Kleine-Weber H., Schroeder S., Kr\u00fcger N., Herrler T., Erichsen S., Schiergens T.S., Herrler G., Wu N.H., Nitsche A., M\u00fcller M.A., Drosten C., P\u00f6hlmann S. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell. 2020;181(2):271\u2013280. doi: 10.1016/j.cell.2020.02.052.", "ArticleIdList": ["10.1016/j.cell.2020.02.052", "PMC7102627", "32142651"]}, {"Citation": "Kirchdoerfer R.N., Ward A.B. Structure of the SARS-CoV nsp12 polymerase bound to nsp7 and nsp8 co-factors. Nat. Commun. 2019;10(1):2342. doi: 10.1038/s41467-019-10280-3. 1-9.", "ArticleIdList": ["10.1038/s41467-019-10280-3", "PMC6538669", "31138817"]}, {"Citation": "Gordon C.J., Tchesnokov E.P., Feng J.Y., Porter D.P., G\u00f6tte M. The antiviral compound remdesivir potently inhibits RNA-dependent RNA polymerase from Middle East respiratory syndrome coronavirus. J. Biol. Chem. 2020;295:4773\u20134779. doi: 10.1074/jbc.AC120.013056.", "ArticleIdList": ["10.1074/jbc.AC120.013056", "PMC7152756", "32094225"]}, {"Citation": "Elfiky A.A. Natural products may interfere with SARS-CoV-2 attachment to the host cell. J. Biomol. Struct. Dyn. 2020;(2020):1\u201310. doi: 10.1080/07391102.2020.1761881. [E-pub ahead of print]", "ArticleIdList": ["10.1080/07391102.2020.1761881", "PMC7212544", "32340551"]}, {"Citation": "Snijder E.J., Decroly E., Ziebuhr J. The nonstructural proteins directing coronavirus RNA synthesis and processing. Adv. Virus Res. 2016;96:59\u2013126. doi: 10.1016/bs.aivir.2016.08.008.", "ArticleIdList": ["10.1016/bs.aivir.2016.08.008", "PMC7112286", "27712628"]}, {"Citation": "Anand K., Ziebuhr J., Wadhwani P., Mesters J.R., Hilgenfeld R. Coronavirus main proteinase (3CLpro) structure: basis for design of anti-SARS drugs. Science. 2003;300(5626):1763\u20131767. doi: 10.1126/science.1085658.", "ArticleIdList": ["10.1126/science.1085658", "12746549"]}, {"Citation": "Khodadadi E., Maroufi P., Khodadadi E., Esposito I., Ganbarov K., Espsoito S., Yousefi M., Zeinalzadeh E., Kafil H.S. Study of combining virtual screening and antiviral treatments of the Sars-CoV-2 (Covid-19) Microb. Pathog. 2020;146:104241. doi: 10.1016/j.micpath.2020.", "ArticleIdList": ["10.1016/j.micpath.2020", "PMC7199731", "32387389"]}, {"Citation": "Stower H. Lopinavir\u2013ritonavir in severe COVID-19. Nat. Med. 2020;26(4) doi: 10.1038/s41591-020-0849-9. 465-465.", "ArticleIdList": ["10.1038/s41591-020-0849-9", "32273604"]}, {"Citation": "McKee D.L., Sternberg A., Stange U., Laufer S., Naujokat C. Candidate drugs against SARS-CoV-2 and COVID-19. Pharmacol. Res. 2020;157:104859. doi: 10.1016/j.phrs.2020.104859.", "ArticleIdList": ["10.1016/j.phrs.2020.104859", "PMC7189851", "32360480"]}, {"Citation": "Wu R., Wang L., Kuo H.D., Shannar A., Peter R., Chou P.J., Li S., Hudlikar R., Liu X., Liu Z., Poiani G.J., Amorosa L., Brunetti L., Kong A.N. An update on current therapeutic drugs treating COVID-19. Current Pharmacology Reports. 2020;2020:1\u201315. doi: 10.1007/s40495-020-00216-7.", "ArticleIdList": ["10.1007/s40495-020-00216-7", "PMC7211915", "32395418"]}, {"Citation": "Shin D., Mukherjee R., Grewe D., Bojkova D., Baek K., Bhattacharya A., Schulz L., Widera M., Mehdipour A.R., Tascher G., Geurink P.P., Wilhelm A., van der Heden van Noort G.J., Ovaa H., M\u00fcller S., Knobeloch K.P., Rajalingam K., Schulman B.A., Cinatl J., Hummer G., Ciesek S., Dikic I. Inhibition of papain-like protease PLpro blocks SARS-CoV-2 spread and promotes anti-viral immunity. Research Square. 2020 doi: 10.1038/s41586-020-2601-5. 2020, (Pre-print)", "ArticleIdList": ["10.1038/s41586-020-2601-5", "PMC7116779", "32726803"]}, {"Citation": "Barretto N., Jukneliene D., Ratia K., Chen Z., Mesecar A.D., Baker S.C. The papain-like protease of severe acute respiratory syndrome coronavirus has deubiquitinating activity. J. Virol. 2005;79(24):15189\u201315198. doi: 10.1128/JVI.79.24.15189-15198.2005.", "ArticleIdList": ["10.1128/JVI.79.24.15189-15198.2005", "PMC1316023", "16306590"]}, {"Citation": "Ha D.P., Van Krieken R., Carlos A.J., Lee A.S. The stress-inducible molecular chaperone GRP78 as potential therapeutic target for coronavirus infection. J. Infect. 2020;81(3):452\u2013482. doi: 10.1016/j.jinf.2020.06.017.", "ArticleIdList": ["10.1016/j.jinf.2020.06.017", "PMC7289740", "32535155"]}, {"Citation": "Zhou N., Pan T., Zhang J., Li Q., Zhang X., Bai C., Huang F., Peng T., Zhang J., Liu C., Tao L., Zhang H. Glycopeptide antibiotics potently inhibit cathepsin L in the late endosome/lysosome and block the entry of Ebola virus, middle east respiratory syndrome coronavirus (MERS-CoV), and severe acute respiratory syndrome coronavirus (SARS-CoV) J. Biol. Chem. 2016;291(17):9218\u20139232. doi: 10.1074/jbc.M116.716100.", "ArticleIdList": ["10.1074/jbc.M116.716100", "PMC4861487", "26953343"]}, {"Citation": "Coleman M.D., Ha S.D., Haeryfar S.M.M., Barr S.D., Kim S.O. Cathepsin B plays a key role in optimal production of the influenza A virus. Journal of Virology and Antiviral Research. 2018:1\u201320. doi: 10.4172/2324-8955.1000178. 2018.", "ArticleIdList": ["10.4172/2324-8955.1000178", "PMC5770218", "29349092"]}, {"Citation": "Inoue Y., Tanaka N., Tanaka Y., Inoue S., Morita K., Zhuang M., Hattori T., Sugamura K. Clathrin-dependent entry of severe acute respiratory syndrome coronavirus into target cells expressing ACE2 with the cytoplasmic tail deleted. J. Virol. 2007;81(16):8722\u20138729. doi: 10.1128/JVI.00253-07.", "ArticleIdList": ["10.1128/JVI.00253-07", "PMC1951348", "17522231"]}, {"Citation": "Wang H., Yang P., Liu K., Guo F., Zhang Y., Zhang G., Jiang C. SARS coronavirus entry into host cells through a novel clathrin-and caveolae-independent endocytic pathway. Cell Res. 2008;18(2):290\u2013301. doi: 10.1038/cr.2008.15.", "ArticleIdList": ["10.1038/cr.2008.15", "PMC7091891", "18227861"]}, {"Citation": "Stancioiu F., Papadakis G.Z., Kteniadakis S., Izotov B.N., Coleman M.D., Spandidos D.A., Tsatsakis A. A dissection of SARS CoV2 with clinical implications. Int. J. Mol. Med. 2020;46(2):489\u2013508. doi: 10.3892/ijmm.2020.4636.", "ArticleIdList": ["10.3892/ijmm.2020.4636", "PMC7307812", "32626922"]}, {"Citation": "Liu T., Luo S., Libby P., Shi G.P. Cathepsin L-selective inhibitors: a potentially promising treatment for COVID-19 patients. Pharmacol. Ther. 2020;213:107587. doi: 10.1016/j.pharmthera.2020.107587.", "ArticleIdList": ["10.1016/j.pharmthera.2020.107587", "PMC7255230", "32470470"]}, {"Citation": "Khan Z., Karatas Y., Ceylan A.F., Rahman H. Le Pharmacien Hospitalier et Clinicien; 2020. COVID-19 and therapeutic drugs repurposing in hand: the need for collaborative efforts. 2020, [E-pub ahead of print]", "ArticleIdList": ["10.1016/j.phclin.2020.06.003"]}, {"Citation": "Yang Y., Islam M.S., Wang J., Li Y., Chen X. Traditional Chinese medicine in the treatment of patients infected with 2019-new coronavirus (SARS-CoV-2): a review and perspective. Int. J. Biol. Sci. 2020;16(10):1708\u20131717. doi: 10.7150/ijbs.45538.", "ArticleIdList": ["10.7150/ijbs.45538", "PMC7098036", "32226288"]}, {"Citation": "Mirzaie A., Halaji M., Dehkordi F.S., Ranjbar R., Noorbazargand H. A narrative literature review on traditional medicine options for treatment of corona virus disease 2019 (COVID-19) Compl. Ther. Clin. Pract. 2020;40:101214. doi: 10.1016/j.ctcp.2020.101214.", "ArticleIdList": ["10.1016/j.ctcp.2020.101214", "PMC7831809", "32891290"]}, {"Citation": "Khaerunnisa S., Kurniawan H., Awaluddin R., Suhartati S., Soetjipto S. Potential Inhibitor of COVID-19 main protease (Mpro) from several medicinal plant compounds by molecular docking study. Preprints. 2020 doi: 10.20944/preprints202003.0226.v1. 2020, 2020030226.", "ArticleIdList": ["10.20944/preprints202003.0226.v1"]}, {"Citation": "Ganjhu R.K., Mudgal P.P., Maity H., Dowarha D., Devadiga S., Nag S., Arunkumar G. Herbal plants and plant preparations as remedial approach for viral diseases. Virusdisease. 2015;26(4):225\u2013236. doi: 10.1007/s13337-015-0276-6.", "ArticleIdList": ["10.1007/s13337-015-0276-6", "PMC4663710", "26645032"]}, {"Citation": "Pillaiyar T., Meenakshisundaram S., Manickam M. Recent discovery and development of inhibitors targeting coronaviruses. Drug Discov. Today. 2020;25(4):668\u2013688. doi: 10.1016/j.drudis.2020.01.015.", "ArticleIdList": ["10.1016/j.drudis.2020.01.015", "PMC7102522", "32006468"]}, {"Citation": "Yi L., Li Z., Yuan K., Qu X., Chen J., Wang G., Zhang H., Luo H., Zhu L., Jiang P., Chen L., Shen Y., Luo M., Zuo G., Hu J., Duan D., Nie Y., Shi X., Wang W., Han Y., Li T., Liu Y., Ding M., Deng H., Xu X. Small molecules blocking the entry of severe acute respiratory syndrome coronavirus into host cells. J. Virol. 2004;78(20):11334\u201311339. doi: 10.1128/JVI.78.20.11334-11339.2004.", "ArticleIdList": ["10.1128/JVI.78.20.11334-11339.2004", "PMC521800", "15452254"]}, {"Citation": "Yu M.S., Lee J., Lee J.M., Kim Y., Chin Y.W., Jee J.G., Keum Y.S., Jeong Y.J. Identification of myricetin and scutellarein as novel chemical inhibitors of the SARS coronavirus helicase, nsP13. Bioorg. Med. Chem. Lett. 2012;22(12):4049\u20134054. doi: 10.1016/j.bmcl.2012.04.081.", "ArticleIdList": ["10.1016/j.bmcl.2012.04.081", "PMC7127438", "22578462"]}, {"Citation": "Zhuang M., Jiang H., Suzuki Y., Li X., Xiao P., Tanaka T., Ling H., Yang B., Saitoh H., Zhang L., Qin C., Sugamura K., Hattori T. Procyanidins and butanol extract of Cinnamomi cortex inhibit SARS-CoV infection. Antivir. Res. 2009;82(1):73\u201381. doi: 10.1016/j.antiviral.2009.02.001.", "ArticleIdList": ["10.1016/j.antiviral.2009.02.001", "PMC7114128", "19428598"]}, {"Citation": "Ryu Y.B., Jeong H.J., Kim J.H., Kim Y.M., Park J.Y., Kim D., Nguyen T.T., Park S.J., Chang J.S., Park K.H., Rho M.C., Lee W.S. Biflavonoids from Torreya nucifera displaying SARS-CoV 3CLpro inhibition. Bioorg. Med. Chem. 2010;18(22):7940\u20137947. doi: 10.1016/j.bmc.2010.09.035.", "ArticleIdList": ["10.1016/j.bmc.2010.09.035", "PMC7126309", "20934345"]}, {"Citation": "Kim D.W., Seo K.H., Curtis-Long M.J., Oh K.Y., Oh J.W., Cho J.K., Lee K.H., Park K.H. Phenolic phytochemical displaying SARS-CoV papain-like protease inhibition from the seeds of Psoralea corylifolia. J. Enzym. Inhib. Med. Chem. 2014;29(1):59\u201363. doi: 10.3109/14756366.2012.753591.", "ArticleIdList": ["10.3109/14756366.2012.753591", "23323951"]}, {"Citation": "Cho J.K., Curtis-Long M.J., Lee K.H., Kim D.W., Ryu H.W., Yuk H.J., Park K.H. Geranylated flavonoids displaying SARS-CoV papain-like protease inhibition from the fruits of Paulownia tomentosa. Bioorg. Med. Chem. 2013;21(11):3051\u20133057. doi: 10.1016/j.bmc.2013.03.027.", "ArticleIdList": ["10.1016/j.bmc.2013.03.027", "PMC7126831", "23623680"]}, {"Citation": "Lin C.W., Tsai F.J., Tsai C.H., Lai C.C., Wan L., Ho T.Y., Hsieh C.C., Chao P.D. Anti-SARS coronavirus 3C-like protease effects of Isatis indigotica root and plant-derived phenolic compounds. Antivir. Res. 2005;68(1):36\u201342. doi: 10.1016/j.antiviral.2005.07.002.", "ArticleIdList": ["10.1016/j.antiviral.2005.07.002", "PMC7114321", "16115693"]}, {"Citation": "Park J.Y., Yuk H.J., Ryu H.W., Lim S.H., Kim K.S., Park K.H., Ryu Y.B., Lee W.S. Evaluation of polyphenols from Broussonetia papyrifera as coronavirus protease inhibitors. J. Enzym. Inhib. Med. Chem. 2017;32(1):504\u2013515. doi: 10.1080/14756366.2016.1265519.", "ArticleIdList": ["10.1080/14756366.2016.1265519", "PMC6010046", "28112000"]}, {"Citation": "Chen C.N., Lin C.P., Huang K.K., Chen W.C., Hsieh H.P., Liang P.H., Hsu J.T. Inhibition of SARS-CoV 3C-like protease activity by theaflavin-3, 3'-digallate (TF3) Evid. base Compl. Alternative Med. 2005;2(2):209\u2013215. doi: 10.1093/ecam/neh081.", "ArticleIdList": ["10.1093/ecam/neh081", "PMC1142193", "15937562"]}, {"Citation": "Park J.Y., Kim J.H., Kwon J.M., Kwon H.J., Jeong H.J., Kim Y.M., Kim D., Lee W.S., Ryu Y.B. Dieckol, a SARS-CoV 3CLpro inhibitor, isolated from the edible brown algae Ecklonia cava. Bioorg. Med. Chem. 2013;21(13):3730\u20133737. doi: 10.1016/j.bmc.2013.04.026.", "ArticleIdList": ["10.1016/j.bmc.2013.04.026", "PMC7126891", "23647823"]}, {"Citation": "Song Y.H., Kim D.W., Curtis-Long M.J., Yuk H.J., Wang Y., Zhuang N., Lee K.H., Jeon K.S., Park K.H. Papain-like protease (PLpro) inhibitory effects of cinnamic amides from Tribulus terrestris fruits. Biol. Pharm. Bull. 2014;37(6):1021\u20131028. doi: 10.1248/bpb.b14-00026.", "ArticleIdList": ["10.1248/bpb.b14-00026", "24882413"]}, {"Citation": "Shen Y.C., Wang L.T., Khalil A.T., Chiang L.C., Cheng P.W. Bioactive pyranoxanthones from the roots of Calophyllum blancoi. Chem. Pharm. Bull. 2005;53(2):244\u2013247. doi: 10.1248/cpb.53.244.", "ArticleIdList": ["10.1248/cpb.53.244", "15684529"]}, {"Citation": "Ho T.Y., Wu S.L., Chen J.C., Li C.C., Hsiang C.Y. Emodin blocks the SARS coronavirus spike protein and angiotensin-converting enzyme 2 interaction. Antivir. Res. 2007;74(2):92\u2013101. doi: 10.1016/j.antiviral.2006.04.014.", "ArticleIdList": ["10.1016/j.antiviral.2006.04.014", "PMC7114332", "16730806"]}, {"Citation": "Loizzo M.R., Saab A.M., Tundis R., Statti G.A., Menichini F., Lampronti I., Gambari R., Cinatl J., Doerr H.W. Phytochemical analysis and in vitro antiviral activities of the essential oils of seven Lebanon species. Chem. Biodivers. 2008;5(3):461\u2013470. doi: 10.1002/cbdv.200890045.", "ArticleIdList": ["10.1002/cbdv.200890045", "PMC7161995", "18357554"]}, {"Citation": "Park J.Y., Kim J.H., Kim Y.M., Jeong H.J., Kim D.W., Park K.H., Kwon H.J., Park S.J., Lee W.S., Ryu Y.B. Tanshinones as selective and slow-binding inhibitors for SARS-CoV cysteine proteases. Bioorg. Med. Chem. 2012;20(19):5928\u20135935. doi: 10.1016/j.bmc.2012.07.038.", "ArticleIdList": ["10.1016/j.bmc.2012.07.038", "PMC7127169", "22884354"]}, {"Citation": "Kumar V., Jung Y.S., Liang P.H. Anti-SARS coronavirus agents: a patent review (2008\u2013present) Expert Opin. Ther. Pat. 2013;23(10):1337\u20131348. doi: 10.1517/13543776.2013.823159.", "ArticleIdList": ["10.1517/13543776.2013.823159", "23905913"]}, {"Citation": "Chang F.R., Yen C.T., Ei-Shazly M., Lin W.H., Yen M.H., Lin K.H., Wu Y.C. Anti-human coronavirus (anti-HCoV) triterpenoids from the leaves of Euphorbia neriifolia. Natural Product Communications. 2012;7(11):1415\u20131417. 2012.", "ArticleIdList": ["23285797"]}, {"Citation": "Orhan I.E., Senol Deniz F.S. Natural products as potential leads against coronaviruses: could they be encouraging structural models against SARS-CoV-2? Natural Products and Bioprospecting. 2020;10(4):1\u201316. doi: 10.1007/s13659-020-00250-4.", "ArticleIdList": ["10.1007/s13659-020-00250-4", "PMC7289229", "32529545"]}, {"Citation": "Tsai Y.C., Lee C.L., Yen H.R., Chang Y.S., Lin Y.P., Huang S.H., Lin C.W. Antiviral action of Tryptanthrin isolated from Strobilanthes cusia leaf against human coronavirus NL63. Biomolecules. 2020;10(3):366. doi: 10.3390/biom10030366.", "ArticleIdList": ["10.3390/biom10030366", "PMC7175275", "32120929"]}, {"Citation": "Kim D.E., Min J.S., Jang M.S., Lee J.Y., Shin Y.S., Song J.H., Kim H.R., Kim S., Jin Y.H., Kwon S. Natural bis-benzylisoquinoline alkaloids-tetrandrine, fangchinoline, and cepharanthine, inhibit human coronavirus OC43 infection of MRC-5 human lung cells. Biomolecules. 2019;9(11):696. doi: 10.3390/biom9110696.", "ArticleIdList": ["10.3390/biom9110696", "PMC6921063", "31690059"]}, {"Citation": "Cheng P.W., Ng L.T., Chiang L.C., Lin C.C. Antiviral effects of saikosaponins on human coronavirus 229E in vitro. Clin. Exp. Pharmacol. Physiol. 2006;33(7):612\u2013616. doi: 10.1111/j.1440-1681.2006.04415.x.", "ArticleIdList": ["10.1111/j.1440-1681.2006.04415.x", "PMC7162031", "16789928"]}, {"Citation": "Muller C., Schulte F.W., Lange-Gr\u00fcnweller K., Obermann W., Madhugiri R., Pleschka S., Ziebuhr J., Hartmann R.K., Gr\u00fcnweller A. Broad-spectrum antiviral activity of the eIF4A inhibitor silvestrol against corona-and picornaviruses. Antivir. Res. 2018;150:123\u2013129. doi: 10.1016/j.antiviral.2017.12.010.", "ArticleIdList": ["10.1016/j.antiviral.2017.12.010", "PMC7113723", "29258862"]}, {"Citation": "Park J.Y., Ko J.A., Kim D.W., Kim Y.M., Kwon H.J., Jeong H.J., Kim C.Y., Park K.H., Lee W.S., Ryu Y.B. Chalcones isolated from Angelica keiskei inhibit cysteine proteases of SARS-CoV. J. Enzym. Inhib. Med. Chem. 2016;31(1):23\u201330. doi: 10.3109/14756366.2014.1003215.", "ArticleIdList": ["10.3109/14756366.2014.1003215", "25683083"]}, {"Citation": "Park J.Y., Jeong H.J., Kim J.H., Kim Y.M., Park S.J., Kim D., Park K.H., Lee W.S., Ryu Y.B. Diarylheptanoids from Alnus japonica inhibit papain-like protease of severe acute respiratory syndrome coronavirus. Biol. Pharm. Bull. 2012;35(11):2036\u20132042. doi: 10.1248/bpb.b12-00623.", "ArticleIdList": ["10.1248/bpb.b12-00623", "22971649"]}, {"Citation": "Kumaki Y., Wandersee M.K., Smith A.J., Zhou Y., Simmons G., Nelson N.M., Bailey K.W., Vest Z.G., Li J.K., Chan P.K., Smee D.F., Barnard D.L. Inhibition of severe acute respiratory syndrome coronavirus replication in a lethal SARS-CoV BALB/c mouse model by stinging nettle lectin, Urtica dioica agglutinin. Antivir. Res. 2011;90(1):22\u201332. doi: 10.1016/j.antiviral.2011.02.003.", "ArticleIdList": ["10.1016/j.antiviral.2011.02.003", "PMC3085190", "21338626"]}, {"Citation": "O'Keefe B.R., Giomarelli B., Barnard D.L., Shenoy S.R., Chan P.K., McMahon J.B., Palmer K.E., Barnett B.W., Meyerholz D.K., Wohlford-Lenane C.L., McCray P.B., Jr. Broad-spectrum in vitro activity and in vivo efficacy of the antiviral protein griffithsin against emerging viruses of the family Coronaviridae. J. Virol. 2020;84(5):2511\u20132521. doi: 10.1128/JVI.02322-09.", "ArticleIdList": ["10.1128/JVI.02322-09", "PMC2820936", "20032190"]}, {"Citation": "Karak P. Biological activities of flavonoids: an overview. Int. J. Pharmaceut. Sci. Res. 2019;10(4):1567\u20131574. doi: 10.13040/IJPSR.0975-8232.10(4). 1567-74.", "ArticleIdList": ["10.13040/IJPSR.0975-8232.10(4)"]}, {"Citation": "Jo S., Kim S., Shin D.H., Kim M.S. Inhibition of SARS-CoV 3CL protease by flavonoids. J. Enzym. Inhib. Med. Chem. 2020;35(1):145\u2013151. doi: 10.1080/14756366.2019.1690480.", "ArticleIdList": ["10.1080/14756366.2019.1690480", "PMC6882434", "31724441"]}, {"Citation": "Ahmad A., Kaleem M., Ahmed Z., Shafiq H. Therapeutic potential of flavonoids and their mechanism of action against microbial and viral infections\u2014a review. Food Res. Int. 2015;77(2):221\u2013235. doi: 10.1016/j.foodres.2015.06.021.", "ArticleIdList": ["10.1016/j.foodres.2015.06.021"]}, {"Citation": "Chauhan A., Kalra S. Identification of potent COVID-19 main protease (MPRO) inhibitors from flavonoids. Research Square. 2020:1\u201311. doi: 10.21203/rs.3.rs-34497/v1. 2020.", "ArticleIdList": ["10.21203/rs.3.rs-34497/v1"]}, {"Citation": "Ngwa W., Kumar R., Thompson D., Lyerly W., Moore R., Reid T.E., Lowe H., Toyang N. Potential of flavonoid-inspired phytomedicines against COVID-19. Molecules. 2020;25(11):2707. doi: 10.3390/molecules25112707.", "ArticleIdList": ["10.3390/molecules25112707", "PMC7321405", "32545268"]}, {"Citation": "Laskin A., Smith J.S., Laskin J. Molecular characterization of nitrogen-containing organic compounds in biomass burning aerosols using high-resolution mass spectrometry. Environ. Sci. Technol. 2009;43(10):3764\u20133771. doi: 10.1021/es803456n.", "ArticleIdList": ["10.1021/es803456n", "19544885"]}, {"Citation": "McMahon J.B., Currens M.J., Gulakowski R.J., Buckheit R.W., Jr., Lackman-Smith C., Hallock Y.F., Boyd M.R. Michellamine B, a novel plant alkaloid, inhibits human immunodeficiency virus-induced cell killing by at least two distinct mechanisms. Antimicrob. Agents Chemother. 1995;39:484\u2013488. doi: 10.1128/aac.39.2.484.", "ArticleIdList": ["10.1128/aac.39.2.484", "PMC162564", "7537029"]}, {"Citation": "Wink M. Potential of DNA intercalating alkaloids and other plant secondary metabolites against SARS-CoV-2 causing COVID-19. Diversity. 2020;12(5):175. doi: 10.3390/d12050175.", "ArticleIdList": ["10.3390/d12050175"]}, {"Citation": "Jahan I., Onay A. Potentials of plant-based substance to inhabit and probable cure for the COVID-19. Turk. J. Biol. 2020;44(3):228\u2013241. doi: 10.3906/biy-2005-114.", "ArticleIdList": ["10.3906/biy-2005-114", "PMC7314514", "32595359"]}, {"Citation": "Srivastava A.K., Kumar A., Misra N. On the inhibition of COVID-19 protease by Indian herbal plants: an in silico investigation. 2020. https://arxiv.org/abs/2004.03411v1 arXiv (preprint) arXiv: 2004.03411 (2020)"}, {"Citation": "Bleasel M.D., Peterson G.M. Emetine, ipecac, ipecac alkaloids and analogues as potential antiviral agents for coronaviruses. Pharmaceuticals. 2020;13(3):51. doi: 10.3390/ph13030051.", "ArticleIdList": ["10.3390/ph13030051", "PMC7151655", "32245264"]}, {"Citation": "Vermerris W., Nicholson R. Springer Science & Business Media; 2007. Phenolic Compound Biochemistry.", "ArticleIdList": ["10.1007/978-1-4020-5164-7"]}, {"Citation": "Cai Y.Z., Sun M., Xing J., Luo Q., Corke H. Structure\u2013radical scavenging activity relationships of phenolic compounds from traditional Chinese medicinal plants. Life Sci. 2006;78(25):2872\u20132888. doi: 10.1016/j.lfs.2005.11.004.", "ArticleIdList": ["10.1016/j.lfs.2005.11.004", "16325868"]}, {"Citation": "Manivannan R., Punniyamoorthy A., Tamilselvan C. Plant secondary metabolites of antiviral properties a rich medicinal source for drug discovery: a mini review. J. Drug Deliv. Therapeut. 2019;9(5):161\u2013167. doi: 10.22270/jddt.v9i5.3471.", "ArticleIdList": ["10.22270/jddt.v9i5.3471"]}, {"Citation": "Rebensburg S., Helfer M., Schneider M., Koppensteiner H., Eberle J., Schindler M., G\u00fcrtler L., Brack-Werner R. Potent in vitro antiviral activity of Cistus incanus extract against HIV and Filoviruses targets viral envelope proteins. Sci. Rep. 2016;6:20394. doi: 10.1038/srep20394.", "ArticleIdList": ["10.1038/srep20394", "PMC4735868", "26833261"]}, {"Citation": "Annunziata G., Sanduzzi Zamparelli M., Santoro C., Ciampaglia R., Stornaiuolo M., Tenore G.C., Sanduzzi A., Novellino E. May polyphenols have a role against coronavirus infection? An overview of in vitro evidence. Front. Med. 2020;7:240. doi: 10.3389/fmed.2020.00240.", "ArticleIdList": ["10.3389/fmed.2020.00240", "PMC7243156", "32574331"]}, {"Citation": "Edris A.E. Pharmaceutical and therapeutic potentials of essential oils and their individual volatile constituents: a review. Phytother Res. 2007;21(4):308\u2013323. doi: 10.1002/ptr.2072.", "ArticleIdList": ["10.1002/ptr.2072", "17199238"]}, {"Citation": "Singh G., Kapoor I.P.S., Singh P., de Heluani C.S., de Lampasona M.P., Catalan C.A.N. Chemistry, antioxidant and antimicrobial investigations on essential oil and oleoresins of Zingiber officinale. Food Chem. Toxicol. 2008;46(10):3295\u20133302. doi: 10.1016/j.fct.2008.07.017.", "ArticleIdList": ["10.1016/j.fct.2008.07.017", "18706468"]}, {"Citation": "Nadjib B.M. Effective antiviral activity of essential oils and their characteristic terpenes against coronaviruses: an update. Journal of Pharmacology & Clinical Toxicology. 2020;8(1):1138."}, {"Citation": "Sharma A.D., Kaur I. Eucalyptol (1, 8 cineole) from eucalyptus essential oil a potential inhibitor of COVID 19 corona virus infection by molecular docking studies. Preprints. 2020 doi: 10.20944/preprints202003.0455.v1. 2020, 2020030455.", "ArticleIdList": ["10.20944/preprints202003.0455.v1"]}, {"Citation": "Carson C.F., Hammer K.A. In: Lipids and Essential Oils as Antimicrobial Agents. Thormar H., editor. John Wiley & Sons Ltd; Chichester: 2011. Chemistry and bioactivity of essential oils; pp. 203\u2013238.", "ArticleIdList": ["10.1002/9780470976623.ch9"]}, {"Citation": "Meneses R., Ocazionez R.E., Mart\u00ednez J.R., Stashenko E.E. Inhibitory effect of essential oils obtained from plants grown in Colombia on yellow fever virus replication in vitro. Ann. Clin. Microbiol. Antimicrob. 2019;8(1):8. doi: 10.1186/1476-0711-8-8.", "ArticleIdList": ["10.1186/1476-0711-8-8", "PMC2661042", "19267922"]}, {"Citation": "Khan M.T., Ather A., Thompson K.D., Gambari R. Extracts and molecules from medicinal plants against herpes simplex viruses. Antivir. Res. 2005;67(2):107\u2013119. doi: 10.1016/j.antiviral.2005.05.002.", "ArticleIdList": ["10.1016/j.antiviral.2005.05.002", "16040137"]}, {"Citation": "Govindarajan M., Rajeswary M., Hoti S.L., Bhattacharyya A., Benelli G. Eugenol, \u03b1-pinene and \u03b2-caryophyllene from Plectranthus barbatus essential oil as eco-friendly larvicides against malaria, dengue and Japanese encephalitis mosquito vectors. Parasitol. Res. 2016;115(2):807\u2013815. doi: 10.1007/s00436-015-4809-0.", "ArticleIdList": ["10.1007/s00436-015-4809-0", "26518773"]}, {"Citation": "Swamy M.K., Akhtar M.S., Sinniah U.R. Antimicrobial properties of plant essential oils against human pathogens and their mode of action: an updated review. Evid. base Compl. Alternative Med. 2016:3012462. doi: 10.1155/2016/3012462. 2016.", "ArticleIdList": ["10.1155/2016/3012462", "PMC5206475", "28090211"]}, {"Citation": "Khan Z.A., Iqbal A., Shahzad S.A. Synthetic approaches toward stilbenes and their related structures. Mol. Divers. 2017;21(2):483\u2013509. doi: 10.1007/s11030-017-9736-9.", "ArticleIdList": ["10.1007/s11030-017-9736-9", "PMC7089417", "28429182"]}, {"Citation": "Reinisalo M., Kaelung A., Koskela A., Kaarniranta K., Karjalainen R.O. Polyphenol stilbenes: molecular mechanisms of defence against oxidative stress and aging-related diseases. Oxidative Medicine and Cellular Longevity. 2015:340520. doi: 10.1155/2015/340520. 2015.", "ArticleIdList": ["10.1155/2015/340520", "PMC4477219", "26180583"]}, {"Citation": "Pandey P., Rane J.S., Chatterjee A., Kumar A., Khan R., Prakash A., Ray S. Targeting SARS-CoV-2 spike protein of COVID-19 with naturally occurring phytochemicals: an in silico study for drug development. J. Biomol. Struct. Dyn. 2020;(2020):1\u201311. doi: 10.1080/07391102.2020.1796811.", "ArticleIdList": ["10.1080/07391102.2020.1796811", "PMC7441770", "32698689"]}, {"Citation": "Wahedi H.M., Ahmad S., Abbasi S.W. Stilbene-based natural compounds as promising drug candidates against COVID-19. J. Biomol. Struct. Dyn. 2020;2020:1\u201310. doi: 10.1080/07391102.2020.1762743.", "ArticleIdList": ["10.1080/07391102.2020.1762743", "32345140"]}, {"Citation": "Li Y.Q., Li Z.L., Zhao W.J., Wen R.X., Meng Q.W., Zeng Y. Synthesis of stilbene derivatives with inhibition of SARS coronavirus replication. Eur. J. Med. Chem. 2006;41(9):1084\u20131089. doi: 10.1016/j.ejmech.2006.03.024.", "ArticleIdList": ["10.1016/j.ejmech.2006.03.024", "PMC7119042", "16875760"]}, {"Citation": "Lin S.C., Ho C.T., Chuo W.H., Li S., Wang T.T., Lin C.C. Effective inhibition of MERS-CoV infection by resveratrol. BMC Infect. Dis. 2017;17(1):1\u201310. doi: 10.1186/s12879-017-2253-8.", "ArticleIdList": ["10.1186/s12879-017-2253-8", "PMC5307780", "28193191"]}, {"Citation": "Kren V., Mart\u00ednkov\u00e1 L. Glycosides in medicine: \u201cthe role of glycosidic residue in biological activity.\u201d. Curr. Med. Chem. 2001;8(11):1303\u20131328. doi: 10.2174/0929867013372193.", "ArticleIdList": ["10.2174/0929867013372193", "11562268"]}, {"Citation": "Emamzadeh-Yazdi S.  Dissertation, University of Pretoria; 2013. Antiviral, antibacterial and cytotoxic activities of South African plants containing cardiac glycosides.http://hdl.handle.net/2263/33163 2013."}, {"Citation": "Wong R.W., Lingwood C.A., Ostrowski M.A., Cabral T., Cochrane A. Cardiac glycoside/aglycones inhibit HIV-1 gene expression by a mechanism requiring MEK1/2-ERK1/2 signaling. Sci. Rep. 2018;8(1):850. doi: 10.1038/s41598-018-19298-x.", "ArticleIdList": ["10.1038/s41598-018-19298-x", "PMC5770468", "29339801"]}, {"Citation": "Loregian A., Mercorelli B., Nannetti G., Compagnin C., Pal\u00f9 G. Antiviral strategies against influenza virus: towards new therapeutic approaches. Cell. Mol. Life Sci. 2014;71(19):3659\u20133683. doi: 10.1007/s00018-014-1615-2.", "ArticleIdList": ["10.1007/s00018-014-1615-2", "PMC11114059", "24699705"]}, {"Citation": "Vanderlinden E., Naesens L. Emerging antiviral strategies to interfere with influenza virus entry. Med. Res. Rev. 2014;34(2):301\u2013339. doi: 10.1002/med.21289.", "ArticleIdList": ["10.1002/med.21289", "PMC7168512", "23801557"]}, {"Citation": "Guo S., Bao L., Li C., Sun J., Zhao R., Cui X. Antiviral activity of iridoid glycosides extracted from Fructus Gardeniae against influenza A virus by PACT-dependent suppression of viral RNA replication. Sci. Rep. 2020;10(1):1897. doi: 10.1038/s41598-020-58443-3.", "ArticleIdList": ["10.1038/s41598-020-58443-3", "PMC7002373", "32024921"]}, {"Citation": "Islam M.T., Sarkar C., El-Kersh D.M., Jamaddar S., Uddin S.J., Shilpi J.A., Mubarak M.S. Phytotherapy Research; 2020. Natural products and their derivatives against coronavirus: a review of the non\u2010clinical and pre\u2010clinical data; p. 2020. [E-pub ahead of print]", "ArticleIdList": ["10.1002/ptr.6700", "32248575"]}, {"Citation": "Kregiel D., Berlowska J., Witonska I., Antolak H., Proestos C., Babic M., Babic L., Zhang B. In: Application and Characterization of Surfactants. Najjar R., editor. IntechOpen; London: 2017. Saponin-based, biological-active surfactants from plants; pp. 183\u2013205.", "ArticleIdList": ["10.5772/68062"]}, {"Citation": "Waller G.R., Yamasaki K. Springer Science & Business Media; 2013. Saponins used in traditional and modern medicine.", "ArticleIdList": ["10.1007/978-1-4899-1367-8"]}, {"Citation": "Roner M.R., Sprayberry J., Spinks M., Dhanji S. Antiviral activity obtained from aqueous extracts of the Chilean soapbark tree (Quillaja saponaria Molina) J. Gen. Virol. 2007;88(1):275\u2013285. doi: 10.1099/vir.0.82321-0.", "ArticleIdList": ["10.1099/vir.0.82321-0", "17170461"]}, {"Citation": "Qin X.J., Zhang L.J., Zhang Y., Ni W., Yang X.Z., Yu Q., Yan H., An L.K., Lui H.Y. Polyphyllosides A\u2013F, six new spirostanol saponins from the stems and leaves of Paris polyphylla var. chinensis. Bioorg. Chem. 2020;99:103788. doi: 10.1016/j.bioorg.2020.103788.", "ArticleIdList": ["10.1016/j.bioorg.2020.103788", "32244126"]}, {"Citation": "Amoros M., Fauconnier B., Girre R.L. In vitro antiviral activity of a saponin from Anagallis arvensis, Primulaceae, against herpes simplex virus and poliovirus. Antivir. Res. 1987;8(1):13\u201325. doi: 10.1016/0166-3542(87)90084-2.", "ArticleIdList": ["10.1016/0166-3542(87)90084-2", "2825589"]}, {"Citation": "Bahbah E.I., Negida A., Nabet M.S. Purposing saikosaponins for the treatment of COVID-19. Med. Hypotheses. 2020;140:109782. doi: 10.1016/j.mehy.2020.109782.", "ArticleIdList": ["10.1016/j.mehy.2020.109782", "PMC7179490", "32353743"]}, {"Citation": "Buzzini P., Arapitsas P., Goretti M., Branda E., Turchetti B., Pinelli P., Ieri F., Romani A. Antimicrobial and antiviral activity of hydrolysable tannins. Mini Rev. Med. Chem. 2008;8(12):1179\u20131187. doi: 10.2174/138955708786140990.", "ArticleIdList": ["10.2174/138955708786140990", "18855732"]}, {"Citation": "Sen S., Chakraborty R., Sridhar C., Reddy Y.S.R., De B. Free radicals, antioxidants, diseases and phytomedicines: current status and future prospect. Int. J. Pharmaceut. Sci. Rev. Res. 2010;3(1):91\u2013100."}, {"Citation": "Uchide N., Toyoda H. Antioxidant therapy as a potential approach to severe influenza-associated complications. Molecules. 2011;16(3):2032\u20132052. doi: 10.3390/molecules16032032.", "ArticleIdList": ["10.3390/molecules16032032", "PMC6259602", "21358592"]}, {"Citation": "Khalifa I., Zhu W., Nafie M.S., Dutta K., Li C. Anti-COVID-19 effects of ten structurally different hydrolysable tannins through binding with the catalytic-closed sites of COVID-19 main protease: an in-silico approach. Preprints. 2020 doi: 10.20944/preprints202003.0277.v1. 2020, 2020030277.", "ArticleIdList": ["10.20944/preprints202003.0277.v1"]}, {"Citation": "Zhang R., Wei D.Q., Du Q.S., Chou K.C. Molecular modeling studies of peptide drug candidates against SARS. Med. Chem. 2006;2(3):309\u2013314. doi: 10.2174/157340606776930736.", "ArticleIdList": ["10.2174/157340606776930736", "16948478"]}, {"Citation": "Pandit R.D., Singh R.K. COVID-19 Ayurveda treatment protocol of governments of Nepal and India: a review and perspective. Applied Science and Technology Annals. 2020;1(1):72\u201380. doi: 10.3126/asta.v1i1.30276.", "ArticleIdList": ["10.3126/asta.v1i1.30276"]}, {"Citation": "Malik E.M., M\u00fcller C.E. Anthraquinones as pharmacological tools and drugs. Med. Res. Rev. 2016;36(4):705\u2013748. doi: 10.1002/med.21391.", "ArticleIdList": ["10.1002/med.21391", "27111664"]}, {"Citation": "Li Y., Jiang J.-G. Health functions and structure\u2013activity relationships of natural anthraquinones from plants. Food & Function. 2018;9(12):6063\u20136080. doi: 10.1039/c8fo01569d.", "ArticleIdList": ["10.1039/c8fo01569d", "30484455"]}, {"Citation": "Schinazi R.F., Chu C.K., Babu J.R., Oswald B.J., Saalmann V., Cannon D.L., Eriksson B.F., Nasr M. Anthraquinones as a new class of antiviral agents against human immunodeficiency virus. Antivir. Res. 1990;13(5):265\u2013272. doi: 10.1016/0166-3542(90)90071-e.", "ArticleIdList": ["10.1016/0166-3542(90)90071-e", "1697740"]}, {"Citation": "Khanal P., Patil B.M., Chand J., Naaz Y. Anthraquinone derivatives as an immune booster and their therapeutic option against COVID-19. Natural Products and Bioprospecting. 2020;1\u201311 doi: 10.1007/s13659-020-00260-2. [E-pub ahead of print]", "ArticleIdList": ["10.1007/s13659-020-00260-2", "PMC7414902", "32772313"]}, {"Citation": "Das S., Roy A.S. Naturally occurring anthraquinones as potential inhibitors of SARS-CoV-2 main protease: a molecular docking study. ChemRxiv. 2020;2020:1\u201324. doi: 10.26434/chemrxiv.12245270.v1. (Pre-print)", "ArticleIdList": ["10.26434/chemrxiv.12245270.v1"]}, {"Citation": "Naithani R., Huma L.C., Holland L.E., Shukla D., McCormick D., Mehta R., Moriarty R.M. Antiviral activity of phytochemicals: a comprehensive review. Mini Rev. Med. Chem. 2008;8(11):1106\u20131133. doi: 10.2174/138955708785909943.", "ArticleIdList": ["10.2174/138955708785909943", "18855727"]}, {"Citation": "Sydiskis R.J., Owen D.G., Lohr J.L., Rosler K.H., Blomster R.N. Inactivation of enveloped viruses by anthraquinones extracted from plants. Antimicrob. Agents Chemother. 1991;35(12):2463\u20132466. doi: 10.1128/aac.35.12.2463.", "ArticleIdList": ["10.1128/aac.35.12.2463", "PMC245413", "1810179"]}, {"Citation": "Ul Qamar M.T., Alqahtani S.M., Alamri M.A., Chen L.L. Structural basis of SARS-CoV-2 3CLpro and anti-COVID-19 drug discovery from medicinal plants. Journal of Pharmaceutical Analysis. 2020;10(4):313\u2013319. doi: 10.1016/j.jpha.2020.03.009.", "ArticleIdList": ["10.1016/j.jpha.2020.03.009", "PMC7156227", "32296570"]}, {"Citation": "Da Silva Antonio A., Moreira Wiedemann L.S., Veiga-Junior V.F. Natural products' role against COVID-19. RSC Adv. 2020;10(39):23379\u201323393. doi: 10.1039/D0RA03774E.", "ArticleIdList": ["10.1039/D0RA03774E", "PMC9122563", "35693131"]}, {"Citation": "Pandit M., Latha N. In silico studies reveal potential antiviral activity of phytochemicals from medicinal plants for the treatment of COVID-19 infection. Research Square. 2020;2020 doi: 10.21203/rs.3.rs-22687/v1. (Pre-print)", "ArticleIdList": ["10.21203/rs.3.rs-22687/v1"]}], "ReferenceList": []}], "History": [{"Year": "2020", "Month": "10", "Day": "22"}, {"Year": "2021", "Month": "3", "Day": "7"}, {"Year": "2021", "Month": "3", "Day": "21"}, {"Year": "2021", "Month": "4", "Day": "3", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "5", "Day": "4", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "4", "Day": "2", "Hour": "20", "Minute": "11"}, {"Year": "2021", "Month": "3", "Day": "30"}], "PublicationStatus": "ppublish", "ArticleIdList": ["33798507", "PMC8008820", "10.1016/j.cbi.2021.109449", "S0009-2797(21)00085-5"]}}], "PubmedBookArticle": []}